The epigenetics of epithelial-mesenchymal plasticity in cancer (original) (raw)

• Polyak, K. & Weinberg, R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265–273 (2009).
  Article CAS PubMed Google Scholar
• Thiery, J.P., Acloque, H., Huang, R.Y. & Nieto, M.A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871–890 (2009).
  Article CAS PubMed Google Scholar
• Scheel, C. et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145, 926–940 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Katoh, Y. & Katoh, M. Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA. Int. J. Mol. Med. 22, 271–275 (2008).
  CAS PubMed Google Scholar
• Moustakas, A. & Heldin, C.H. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 98, 1512–1520 (2007).
  Article CAS PubMed Google Scholar
• De Craene, B. & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97–110 (2013).
  Article CAS PubMed Google Scholar
• Zheng, H. & Kang, Y. Multilayer control of the EMT master regulators. Oncogene published online, doi:10.1038/onc.2013.128 (22 April 2013).
  Article CAS PubMed Google Scholar
• Mani, S.A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715 (2008).
  CAS PubMed PubMed Central Google Scholar
• Guo, W. et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015–1028 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gregory, P.A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593–601 (2008).
  Article CAS PubMed Google Scholar
• Peinado, H., Olmeda, D. & Cano, A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7, 415–428 (2007).
  Article CAS PubMed Google Scholar
• Wellner, U. et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 11, 1487–1495 (2009).
  Article CAS PubMed Google Scholar
• Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927–939 (2004).
  Article CAS PubMed Google Scholar
• Savagner, P., Yamada, K.M. & Thiery, J.P. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J. Cell Biol. 137, 1403–1419 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Blanco, M.J. et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21, 3241–3246 (2002).
  Article CAS PubMed Google Scholar
• Ocaña, O.H. et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709–724 (2012).
  Article CAS PubMed Google Scholar
• Tsai, J.H., Donaher, J.L., Murphy, D.A., Chau, S. & Yang, J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725–736 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 (2002).
  Article CAS PubMed Google Scholar
• Agger, K., Christensen, J., Cloos, P.A. & Helin, K. The emerging functions of histone demethylases. Curr. Opin. Genet. Dev. 18, 159–168 (2008).
  Article CAS PubMed Google Scholar
• Nieto, M.A. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu. Rev. Cell Dev. Biol. 27, 347–376 (2011).
  Article CAS PubMed Google Scholar
• Morel, A.P. et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3, e2888 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Rhim, A.D. et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349–361 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Z. et al. Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype. J. Cell Physiol. 228, 556–562 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Albino, D. et al. ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features. Cancer Res. 72, 2889–2900 (2012).
  Article CAS PubMed Google Scholar
• Mulholland, D.J. et al. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res. 72, 1878–1889 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Morel, A.P. et al. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet. 8, e1002723 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Carey, L., Winer, E., Viale, G., Cameron, D. & Gianni, L. Triple-negative breast cancer: disease entity or title of convenience? Nat. Rev. Clin. Oncol. 7, 683–692 (2010).
  Article PubMed Google Scholar
• Sarrió, D. et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 68, 989–997 (2008).
  Article CAS PubMed Google Scholar
• Blick, T. et al. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44hi/CD24lo/– stem cell phenotype in human breast cancer. J. Mammary Gland Biol. Neoplasia 15, 235–252 (2010).
  Article PubMed Google Scholar
• Blick, T. et al. Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin. Exp. Metastasis 25, 629–642 (2008).
  Article CAS PubMed Google Scholar
• Trelstad, R.L., Hay, E.D. & Revel, J.D. Cell contact during early morphogenesis in the chick embryo. Dev. Biol. 16, 78–106 (1967).
  Article CAS PubMed Google Scholar
• Arnoux, V., Nassour, M., L'Helgoualc'h, A., Hipskind, R.A. & Savagner, P. Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol. Biol. Cell 19, 4738–4749 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Micalizzi, D.S., Farabaugh, S.M. & Ford, H.L. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J. Mammary Gland Biol. Neoplasia 15, 117–134 (2010).
  Article PubMed PubMed Central Google Scholar
• Bednarz-Knoll, N., Alix-Panabieres, C. & Pantel, K. Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer Metastasis Rev. 31, 673–687 (2012).
  Article CAS PubMed Google Scholar
• Chao, Y., Wu, Q., Acquafondata, M., Dhir, R. & Wells, A. Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron. 5, 19–28 (2012).
  Article CAS PubMed Google Scholar
• Leroy, P. & Mostov, K.E. Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol. Biol. Cell 18, 1943–1952 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Theveneau, E. & Mayor, R. Neural crest delamination and migration: from epithelium-to-mesenchyme transition to collective cell migration. Dev. Biol. 366, 34–54 (2012).
  Article CAS PubMed Google Scholar
• Gupta, P.B. et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633–644 (2011).
  Article CAS PubMed Google Scholar
• Chaffer, C.L. et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl. Acad. Sci. USA 108, 7950–7955 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Schwitalla, S. et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell–like properties. Cell 152, 25–38 (2013).
  Article CAS PubMed Google Scholar
• Frisch, S.M. The epithelial cell default-phenotype hypothesis and its implications for cancer. Bioessays 19, 705–709 (1997).
  Article CAS PubMed Google Scholar
• Jechlinger, M. et al. Autocrine PDGFR signaling promotes mammary cancer metastasis. J. Clin. Invest. 116, 1561–1570 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Sparmann, A. & van Lohuizen, M. Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 6, 846–856 (2006).
  Article CAS PubMed Google Scholar
• Pietersen, A.M. & van Lohuizen, M. Stem cell regulation by polycomb repressors: postponing commitment. Curr. Opin. Cell Biol. 20, 201–207 (2008).
  Article CAS PubMed Google Scholar
• Orlando, V. Polycomb, epigenomes, and control of cell identity. Cell 112, 599–606 (2003).
  Article CAS PubMed Google Scholar
• Cedar, H. & Bergman, Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10, 295–304 (2009).
  Article CAS PubMed Google Scholar
• Bracken, A.P. & Helin, K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer 9, 773–784 (2009).
  Article CAS PubMed Google Scholar
• Bracken, A.P., Dietrich, N., Pasini, D., Hansen, K.H. & Helin, K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 20, 1123–1136 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Cao, Q. et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27, 7274–7284 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Herranz, N. et al. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol. Cell Biol. 28, 4772–4781 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Iliopoulos, D. et al. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol. Cell 39, 761–772 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Zaret, K.S. & Carroll, J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25, 2227–2241 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wright, M.H. et al. Brca1 breast tumors contain distinct CD44+/CD24– and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res. 10, R10 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chang, C.J. et al. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1–β-catenin signaling. Cancer Cell 19, 86–100 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Collett, K. et al. Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. Clin. Cancer Res. 12, 1168–1174 (2006).
  Article CAS PubMed Google Scholar
• Kleer, C.G. et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. USA 100, 11606–11611 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Puppe, J. et al. BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2–inhibitor 3-deazaneplanocin A. Breast Cancer Res. 11, R63 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Onder, T.T. et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68, 3645–3654 (2008).
  Article CAS PubMed Google Scholar
• Mills, A.A. Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nat. Rev. Cancer 10, 669–682 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Molofsky, A.V. et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425, 962–967 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Iwama, A. et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 21, 843–851 (2004).
  Article CAS PubMed Google Scholar
• Sangiorgi, E. & Capecchi, M.R. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 40, 915–920 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sangiorgi, E. & Capecchi, M.R. Bmi1 lineage tracing identifies a self-renewing pancreatic acinar cell subpopulation capable of maintaining pancreatic organ homeostasis. Proc. Natl. Acad. Sci. USA 106, 7101–7106 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lobo, N.A., Shimono, Y., Qian, D. & Clarke, M.F. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 23, 675–699 (2007).
  Article CAS PubMed Google Scholar
• Valk-Lingbeek, M.E., Bruggeman, S.W. & van Lohuizen, M. Stem cells and cancer; the polycomb connection. Cell 118, 409–418 (2004).
  Article CAS PubMed Google Scholar
• Pardal, R., Molofsky, A.V., He, S. & Morrison, S.J. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Cold Spring Harb. Symp. Quant. Biol. 70, 177–185 (2005).
  Article CAS PubMed Google Scholar
• Park, I.K., Morrison, S.J. & Clarke, M.F. Bmi1, stem cells, and senescence regulation. J. Clin. Invest. 113, 175–179 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Song, L.B. et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J. Clin. Invest. 119, 3626–3636 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Martin, A. & Cano, A. Tumorigenesis: Twist1 links EMT to self-renewal. Nat. Cell Biol. 12, 924–925 (2010).
  Article CAS PubMed Google Scholar
• Yang, M.H. et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat. Cell Biol. 12, 982–992 (2010).
  Article CAS PubMed Google Scholar
• Peinado, H., Ballestar, E., Esteller, M. & Cano, A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell Biol. 24, 306–319 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• von Burstin, J. et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. Gastroenterology 137, 361–371, 371.e1–5 (2009).
  Article CAS PubMed Google Scholar
• Lin, Y. et al. The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1. EMBO J. 29, 1803–1816 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Fu, J. et al. The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res. 21, 275–289 (2011).
  Article CAS PubMed Google Scholar
• Shi, Y. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941–953 (2004).
  Article CAS PubMed Google Scholar
• Harris, W.J. et al. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell 21, 473–487 (2012).
  Article CAS PubMed Google Scholar
• Lim, S. et al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31, 512–520 (2010).
  Article CAS PubMed Google Scholar
• Lin, T., Ponn, A., Hu, X., Law, B.K. & Lu, J. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 29, 4896–4904 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Schenk, T. et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-_trans_–retinoic acid differentiation pathway in acute myeloid leukemia. Nat. Med. 18, 605–611 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y. et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 138, 660–672 (2009).
  Article CAS PubMed Google Scholar
• Metzger, E. et al. LSD1 demethylates repressive histone marks to promote androgen-receptor–dependent transcription. Nature 437, 436–439 (2005).
  Article CAS PubMed Google Scholar
• Bernstein, B.E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315–326 (2006).
  Article CAS PubMed Google Scholar
• Chaffer, C.L. et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154, 61–74 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Maruyama, R. et al. Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium. PLoS Genet. 7, e1001369 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Vallés, A.M. et al. Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc. Natl. Acad. Sci. USA 87, 1124–1128 (1990).
  Article PubMed PubMed Central Google Scholar
• Dong, C. et al. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J. Clin. Invest. 122, 1469–1486 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Dong, C. et al. Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. Oncogene 32, 1351–1362 (2013).
  Article CAS PubMed Google Scholar
• Ke, X.S. et al. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genomics 11, 669 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Bert, S.A. et al. Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell 23, 9–22 (2013).
  Article CAS PubMed Google Scholar
• Zouridis, H. et al. Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci. Transl. Med. 4, 156ra140 (2012).
  Article CAS PubMed Google Scholar
• Coolen, M.W. et al. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat. Cell Biol. 12, 235–246 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Easwaran, H. & Baylin, S.B. Epigenetic abnormalities in cancer find a “home on the range”. Cancer Cell 23, 1–3 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Creighton, C.J. et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl. Acad. Sci. USA 106, 13820–13825 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Li, X. et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl. Cancer Inst. 100, 672–679 (2008).
  Article CAS PubMed Google Scholar
• Singh, A. & Settleman, J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29, 4741–4751 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Diehn, M. et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458, 780–783 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ceppi, P. et al. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol. Cancer Res. 8, 1207–1216 (2010).
  Article CAS PubMed Google Scholar
• Vrba, L. et al. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS ONE 5, e8697 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Eades, G. et al. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J. Biol. Chem. 286, 25992–26002 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tryndyak, V.P., Beland, F.A. & Pogribny, I.P. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int. J. Cancer 126, 2575–2583 (2010).
  CAS PubMed Google Scholar
• Daskalakis, M. et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood 100, 2957–2964 (2002).
  Article CAS PubMed Google Scholar
• Petti, M.C. et al. Complete remission through blast cell differentiation in PLZF/RARα-positive acute promyelocytic leukemia: in vitro and in vivo studies. Blood 100, 1065–1067 (2002).
  Article CAS PubMed Google Scholar
• Shaker, S., Bernstein, M., Momparler, L.F. & Momparler, R.L. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells. Leuk. Res. 27, 437–444 (2003).
  Article CAS PubMed Google Scholar
• Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G. & Baylin, S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21, 103–107 (1999).
  Article CAS PubMed Google Scholar
• Lengauer, C. Cancer. An unstable liaison. Science 300, 442–443 (2003).
  Article CAS PubMed Google Scholar
• Gaudet, F. et al. Induction of tumors in mice by genomic hypomethylation. Science 300, 489–492 (2003).
  Article CAS PubMed Google Scholar
• Eden, A., Gaudet, F., Waghmare, A. & Jaenisch, R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300, 455 (2003).
  Article CAS PubMed Google Scholar
• Yang, A.S., Estecio, M.R., Garcia-Manero, G., Kantarjian, H.M. & Issa, J.P. Comment on “Chromosomal instability and tumors promoted by DNA hypomethylation” and “Induction of tumors in nice by genomic hypomethylation”. Science 302, 1153 (2003).
  Article CAS PubMed Google Scholar
• Bruzzese, F. et al. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT. J. Cell. Physiol. 226, 2378–2390 (2011).
  Article CAS PubMed Google Scholar
• Lei, W. et al. Histone deacetylase 1 is required for transforming growth factor-β1–induced epithelial-mesenchymal transition. Int. J. Biochem. Cell Biol. 42, 1489–1497 (2010).
  Article CAS PubMed Google Scholar
• Kaimori, A. et al. Histone deacetylase inhibition suppresses the transforming growth factor β1–induced epithelial-to-mesenchymal transition in hepatocytes. Hepatology 52, 1033–1045 (2010).
  Article CAS PubMed Google Scholar
• Jiang, G.M. et al. Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression. Biochim. Biophys. Acta 1833, 663–671 (2013).
  Article CAS PubMed Google Scholar
• Kong, D. et al. Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells. PLoS ONE 7, e45045 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067–1073 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Delmore, J.E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904–917 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Whyte, W.A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307–319 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Lovén, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320–334 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Daigle, S.R. et al. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 20, 53–65 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Knutson, S.K. et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat. Chem. Biol. 8, 890–896 (2012).
  Article CAS PubMed Google Scholar
• Finn, R.S. et al. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/”triple-negative” breast cancer cell lines growing in vitro. Breast Cancer Res. Treat. 105, 319–326 (2007).
  Article CAS PubMed Google Scholar
• Tam, W.L. et al. Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell 24, 347–364 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Bonde, A.K., Tischler, V., Kumar, S., Soltermann, A. & Schwendener, R.A. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer 12, 35 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gao, M.Q. et al. Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition–like state in breast cancer cells in vitro. J. Cell Sci. 123, 3507–3514 (2010).
  Article CAS PubMed Google Scholar
• van Zijl, F. et al. Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene 28, 4022–4033 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Li, H.J., Reinhardt, F., Herschman, H.R. & Weinberg, R.A. Cancer-stimulated mesenchymal stem cells create a carcinoma stem-cell niche via Prostaglandin E2 signaling. Cancer Discov. 2, 840–855 (2012).
  Article CAS PubMed Google Scholar
• Wyckoff, J.B. et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67, 2649–2656 (2007).
  Article CAS PubMed Google Scholar
• Yu, M. et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580–584 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Brabletz, T. To differentiate or not—routes towards metastasis. Nat. Rev. Cancer 12, 425–436 (2012).
  Article CAS PubMed Google Scholar
• Brabletz, S. & Brabletz, T. The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer? EMBO Rep. 11, 670–677 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Bracken, C.P. et al. A double-negative feedback loop between ZEB1–SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 68, 7846–7854 (2008).
  Article CAS PubMed Google Scholar
• Chang, C.J. et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat. Cell Biol. 13, 317–323 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Acloque, H., Adams, M.S., Fishwick, K., Bronner-Fraser, M. & Nieto, M.A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 119, 1438–1449 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Thiery, J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442–454 (2002).
  Article CAS PubMed Google Scholar
• Zavadil, J. & Bottinger, E.P. TGF-β and epithelial-to-mesenchymal transitions. Oncogene 24, 5764–5774 (2005).
  Article CAS PubMed Google Scholar
• Taylor, M.A., Parvani, J.G. & Schiemann, W.P. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-β in normal and malignant mammary epithelial cells. J. Mammary Gland Biol. Neoplasia 15, 169–190 (2010).
  Article PubMed PubMed Central Google Scholar
• Han, G. et al. Distinct mechanisms of TGF-β1–mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J. Clin. Invest. 115, 1714–1723 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Lehmann, K. et al. Raf induces TGFβ production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14, 2610–2622 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Oft, M., Heider, K.H. & Beug, H. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8, 1243–1252 (1998).
  Article CAS PubMed Google Scholar
• Xi, Q. et al. A poised chromatin platform for TGF-β access to master regulators. Cell 147, 1511–1524 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• McDonald, O.G., Wu, H., Timp, W., Doi, A. & Feinberg, A.P. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat. Struct. Mol. Biol. 18, 867–874 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Vermeulen, L. et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 12, 468–476 (2010).
  Article CAS PubMed Google Scholar
• Moon, R.T., Kohn, A.D., De Ferrari, G.V. & Kaykas, A. WNT and β-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5, 691–701 (2004).
  Article CAS PubMed Google Scholar
• Taketo, M.M. Shutting down Wnt signal-activated cancer. Nat. Genet. 36, 320–322 (2004).
  Article CAS PubMed Google Scholar
• Liu, B.Y., McDermott, S.P., Khwaja, S.S. & Alexander, C.M. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc. Natl. Acad. Sci. USA 101, 4158–4163 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Mohamed, O.A., Clarke, H.J. & Dufort, D. β-catenin signaling marks the prospective site of primitive streak formation in the mouse embryo. Dev. Dyn. 231, 416–424 (2004).
  Article CAS PubMed Google Scholar
• Kemler, R. et al. Stabilization of β-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast. Development 131, 5817–5824 (2004).
  Article CAS PubMed Google Scholar
• Kim, K., Lu, Z. & Hay, E.D. Direct evidence for a role of β-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol. Int. 26, 463–476 (2002).
  Article CAS PubMed Google Scholar
• Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843–850 (2005).
  Article CAS PubMed Google Scholar
• Yook, J.I. et al. A Wnt-Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 8, 1398–1406 (2006).
  Article CAS PubMed Google Scholar
• Gilles, C. et al. Transactivation of vimentin by β-catenin in human breast cancer cells. Cancer Res. 63, 2658–2664 (2003).
  CAS PubMed Google Scholar
• Kong, D. et al. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells 26, 1425–1435 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Brabletz, S. et al. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J. 30, 770–782 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Thomson, S. et al. A systems view of epithelial-mesenchymal transition signaling states. Clin. Exp. Metastasis 28, 137–155 (2011).
  Article CAS PubMed Google Scholar
• Hardy, K.M., Booth, B.W., Hendrix, M.J., Salomon, D.S. & Strizzi, L. ErbB/EGF signaling and EMT in mammary development and breast cancer. J. Mammary Gland Biol. Neoplasia 15, 191–199 (2010).
  Article PubMed PubMed Central Google Scholar
• Sakai, D. et al. Regulation of Slug transcription in embryonic ectoderm by β-catenin–Lef/Tcf and BMP-Smad signaling. Dev. Growth Differ. 47, 471–482 (2005).
  Article CAS PubMed Google Scholar
• Sánchez-Tilló, E. et al. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc. Natl. Acad. Sci. USA 108, 19204–19209 (2011).
  Article PubMed PubMed Central Google Scholar
• Kim, T. et al. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med. 208, 875–883 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Korpal, M., Lee, E.S., Hu, G. & Kang, Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283, 14910–14914 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Park, S.M., Gaur, A.B., Lengyel, E. & Peter, M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894–907 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Davalos, V. et al. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 31, 2062–2074 (2012).
  Article CAS PubMed Google Scholar
• Neves, R. et al. Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells. BMC Res. Notes 3, 219 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Wiklund, E.D. et al. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int. J. Cancer 128, 1327–1334 (2011).
  Article CAS PubMed Google Scholar
• Tellez, C.S. et al. EMT and stem cell–like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res. 71, 3087–3097 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kasinski, A.L. & Slack, F.J. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer 11, 849–864 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kong, Y.W., Ferland-McCollough, D., Jackson, T.J. & Bushell, M. microRNAs in cancer management. Lancet Oncol. 13, e249–e258 (2012).
  Article CAS PubMed Google Scholar
• Rinn, J.L. & Chang, H.Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145–166 (2012).
  Article CAS PubMed Google Scholar
• Prensner, J.R. & Chinnaiyan, A.M. The emergence of lncRNAs in cancer biology. Cancer Discov. 1, 391–407 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Gupta, R.A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071–1076 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Rinn, J.L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311–1323 (2007).
  Article CAS PubMed PubMed Central Google Scholar